Stockreport

Sarepta Therapeutics gets FDA green light to resume Elevidys for DMD [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF Investing.com -- The U.S. Food and Drug Administration has recommended lifting the voluntary hold on Sarepta Therapeutics (NASDAQ:SRPT)' gene therapy Elevidys for ambula [Read more]